Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells

Abstract

To investigate the effect of p33ING1 on wild-type p53 gene therapy, T.Tn human esophageal carcinoma cells were stably transfected with p33ING1 cDNA. Infection with Ad-p53 (recombinant adenovirus containing wild-type p53) into p33-transfected cells reduced cell viability, while infection with empty vector had little effect. This reduced viability was shown to be due to apoptotic cell death by the TUNEL (terminal deoxynucleotidyl transferase-mediated nick end-labeling) assay. Following infection with Ad-p53, levels of p53 were similar in p33-expressing cells and in the parental line. However, levels of p21 and Mdm2 were elevated in p33-transfected cells. Nonetheless, this enhanced expression of Mdm2 appeared to be ineffective in downregulating p53. Transient transfection with mutant Mdm2 prior to Ad-p53 infection provided a significant protection as compared with cells transfected with wild-type Mdm2. These results imply a synergistic effect between p33 and p53 in the induction of apoptosis of human esophageal carcinoma cells. A role for Mdm2 in this synergism is suggested.

This is a preview of subscription content, access via your institution

Access options

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

wtp53:

wild type p53

Ad-p53:

recombinant wild-type p53 adenoviral vector

Ad-LZ:

recombinant LacZ adenoviral vector

CMV:

cytomegalovirus

MOI:

multiplicity of infection

MTT:

3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide

PBS:

phosphate-buffered saline

TUNEL:

terminal deoxynucleotidyl transferase-mediated nick end-labeling

BaP:

benzo[a]pyrene

ALLN:

acetyl-Leu-Leu-norleucinal

References

  • Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S . 1999 EMBO J. 18: 1223–1234

  • Aschele C, Sobrero A, Faderan MA, Bertino JR . 1992 Cancer Res. 52: 1855–1864

  • Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B . 1990 Science 249: 912–915

  • Barak Y, Oren M . 1992 EMBO J. 11: 2115–2121

  • Bargou BRC, Wagener C, Bommert K, Arnold W, Daniel PT, Mapara MY, Grinstein E, Royer HD, Dörken B . 1996 J. Exp. Med. 183: 1205–1213

  • Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu S, Kusters I, Resau JH, Trump BF, Lane DP, Harris CC . 1992 Cancer Res. 52: 6092–6097

  • Bissonnette N, Hunting DJ . 1998 Oncogene 16: 3461–3469

  • Buckbinder L, Talbott R, Velasco-Miguel L, Takenaka I, Faha B, Seizinger BR, Kley N . 1995 Nature 377: 646–649

  • Chang Y-C, Nakajima H, Illenye S, Lee YS, Honjo N, Makiyama T, Fujiwara I, Mizuta N, Sawai K, Saida K, Mitsui Y, Heintz NH, Magae J . 2000 Oncogene 19: 4713–4720

  • Chen J, Wu X, Lin J, Levine AJ . 1996 Mol. Cell. Biol. 16: 2445–2452

  • Chen PL, Chen Y, Bookstein R, Lee WH . 1990 Science 250: 1576–1580

  • Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K, Tanaka N . 2001 Cancer Res. 61: 4345–4349

  • Cheung Jr K-J, Mitchell D, Lin P, Li G . 2001 Cancer Res. 61: 4974–4977

  • DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250

  • Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH . 1990 Mol. Cell. Biol. 10: 5772–5781

  • Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA . 1998 Oncogene 17: 867–876

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M . 1989 Proc. Natl. Acad. Sci. USA 86: 8763–8767

  • Fakharzadeh SS, Trusko SP, George DL . 1991 EMBO J. 10: 1565–1569

  • Finlay CA, Hinds PW, Levine AJ . 1989 Cell 57: 1083–1093

  • Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV . 1998 Nature 391: 295–298

  • Garkavtsev I, Kazarov A, Gudkov A, Riabowol K . 1996 Nat. Genet. 14: 415–420

  • Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z . 1992 Int. J. Oncol. 1: 639–648

  • Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K . 2000 Cancer Res. 60: 3143–3146

  • Gu Y, Turch CW, Morgan DO . 1993 Nature 366: 707–710

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816

  • Haupt Y, Barak Y, Oren M . 1996 EMBO J. 15: 1596–1606

  • Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299

  • Helbing CC, Veillette C, Riabowol K, Johnston RN, Garkavtsev I . 1997 Cancer Res. 57: 1255–1258

  • Hiwasa T, Sakiyama S . 1996 Cancer Lett. 99: 87–91

  • Hiwasa T, Sawada T, Sakiyama S . 1990 Carinogenesis 11: 75–80

  • Hiwasa T, Sawada T, Sakiyama S . 1996a J. Biol. Chem. 271: 9181–9184

  • Hiwasa T, Soeda C, Takanohashi S, Kobayashi H, Suzuki A, Ueyama T, Ike Y . 1996b Int. J. Oncol. 8: 125–129

  • Hiwasa T, Tanigawara C, Sakiyama S . 1987 Cancer Res 47: 953–959

  • Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC . 1990 Proc. Natl. Acad. Sci. USA 87: 9958–9961

  • Houghton JA, Weiss KD, Williams LG, Torrance PM, Houghton PJ . 1986 Biochem. Pharmacol. 35: 1351–1358

  • Hsing A, Faller DV, Vaziri C . 2000 J. Biol. Chem. 275: 26024–26031

  • Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, Tanaka N . 1997 Oncogene 15: 1903–1909

  • Knudsen ES, Wang JYJ . 1996 J. Biol. Chem. 271: 8313–8320

  • Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JYJ, Knudsen ES . 2000 Mol. Cell. Biol. 20: 7751–7763

  • Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T . 1999 Am. J. Surg. 177: 497–502

  • Kubbutat MH, Jones SN, Vousden KH . 1997 Nature 387: 299–303

  • Lu Y, Yamagishi N, Yagi T, Takebe H . 1998 Oncogene 16: 705–712

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Mosmann T . 1983 J. Immunol. Method. 65: 55–63

  • Nabeya Y, Loganzo Jr F, Maslak P, Lai L, De Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP . 1995 Int. J. Cancer. 64: 37–46

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N . 2000a Science 288: 1053–1058

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000b Cell 102: 849–862

  • Ohmori M, Nagai M, Tasaka T, Koeffer HP, Ribowol K, Takahara J . 1999 Am. J. Hematol. 62: 118–119

  • Oka M, Hirose K, Iizuka N, Aoyagi K, Yamamoto K, Abe T, Hazama S, Suzuki T . 1995 J. Interferon Cytokine Res. 15: 1005–1009

  • Okamoto K, Prives C . 1999 Oncogene 18: 4606–4615

  • Oki E, Maehara Y, Tokunaga E, Kakeji Y, Sugimachi K . 1999 Cancer Lett. 147: 157–162

  • Oren M . 1999 J. Biol. Chem. 274: 36031–36034

  • Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, Radinsky R . 1995 Mol. Cell. Biol. 15: 3032–3040

  • Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305

  • Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D . 1996 Nat. Med. 2: 985–991

  • Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, Yamatsuji T, Nisizaki M, Roth JA, Tanaka N . 2000 Oncogene 19: 726–736

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Shimada H, Shimizu T, Ochiai T, Liu T-L, Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S, Hiwasa T . 2001 Surg. Today 31: 597–604

  • Shinoura N, Muramatsu Y, Nisimura M, Yoshida Y, Saito A, Yokoyama T, Furukawa T, Horii A, Hasimoto M, Asai A, Kirino T, Hamada H . 1999 Cancer Res. 59: 5521–5528

  • Sionov RV, Moallem E, Berger M, Kazaz A, Gerlitz O, Ben-Neriah Y, Oren M, Haupt Y . 1999 J. Biol. Chem. 274: 8371–8374

  • Sun P, Dong P, Dai K, Hannon GJ, Beach D . 1998 Science 282: 2270–2272

  • Takahashi K, Kanazawa H, Chan C-T, Hosono T, Takahara M, Sato K . 1990 Jpn. J. Oral. Maxillofac. Surg. 36: 307–316

  • Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K . 1999 Oncogene 18: 5187–5193

  • Tokunaga E, Maehara Y, Oki E, Kitamura K, Kakeji Y, Ohno S, Sugimachi K . 2000 Cancer Lett. 152: 15–22

  • Wu GS, Saftig P, Peters C, El-Deiry WS . 1998 Oncogene 16: 2177–2183

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . 1993 Nature 366: 701–704

  • Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M . 1991 Nature 352: 345–347

  • Zarkowska T, Mittnacht S . 1997 J. Biol. Chem. 272: 12738–12746

  • Zhang WW, Alemany R, Wang J, Koch PE, Ordonez NG, Roth JA . 1995 Hum. Gene Ther. 6: 155–164

  • Zhu J, Chen X . 2000 Mol. Cell. Biol. 20: 5602–5618

Download references

Acknowledgements

The authors thank Dr Toshiyoshi Fujiwara (Okayama University Medical School) for providing us with adenoviral vectors and also for excellent advice on preparation of the vectors. This work was partly supported by an Advanced Medicine Development Project from the Ministry of Education, Science, Sports and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takaki Hiwasa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, H., Liu, TL., Ochiai, T. et al. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells. Oncogene 21, 1208–1216 (2002). https://doi.org/10.1038/sj.onc.1205176

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205176

Keywords

This article is cited by

Search

Quick links